| NCT Number | NCT07221123 |
| Lead Sponsor | University of Alabama at Birmingham |
| Conditions | HIV (Human Immunodeficiency Virus) |
| Enrollment | 80 participants |
| Start Date | 2026-05-02 |
| Primary Completion | 2027-07-01 (estimated) |
| Study Completion | 2027-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-11 |